Piperazine

Piperazine

SCHEMBL28135603

C1CNCCN1.NC(=O)N1C=CC=CC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40708 0.90
SCHEMBL28246000 0.83 SMN1; SMN2 (0.35)
Piperazine SCHEMBL27841791 0.82
Pyrrole SCHEMBL28201580 0.81
Piperazine SCHEMBL28139461 0.81
SCHEMBL28245243 0.81 HRH2 (0.34)
SCHEMBL8865924 0.77
SCHEMBL28181859 0.76 DPP4 (0.31)
SCHEMBL30587626 0.76
Pyrrolidine SCHEMBL28229892 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109923108-A Pyridyl-substituted indole compounds 百时美施贵宝公司 2019-06-21 CN claimed
CN-109661392-A For treating the mitochondrial inhibitors of proliferative disorder 巴斯利尔药物国际股份公司 2019-04-19 CN claimed
CN-109071548-A It can be used for treating the pyrroles's benzimidazole derivative or its analog of especially cancer 埃姆库瑞医药品有限公司 2018-12-21 CN claimed
CN-104370909-B Tricyclic compound ABBVIE 公司 2018-09-11 CN claimed
CN-108473495-A Purinones as ubiquitin-specific protease 1 inhibitors 福马治疗有限公司 2018-08-31 CN claimed
CN-108473465-A CGRP receptor antagonist 赫普塔瑞斯医疗有限公司 2018-08-31 CN claimed
CN-110139861-A Pyran derivatives as inhibitors of CYP11A1 (cytochrome P450 monooxygenase 11A1) 奥赖恩公司 2019-08-16 CN disclosed
CN-107001271-B Hydroxyamidine derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2019-05-10 CN disclosed
CN-109661392-A For treating the mitochondrial inhibitors of proliferative disorder 巴斯利尔药物国际股份公司 2019-04-19 CN disclosed
CN-109415381-A Thiazolopyridine derivatives as GPR119 agonist 人类制药有限公司 2019-03-01 CN disclosed
CN-109071548-A It can be used for treating the pyrroles's benzimidazole derivative or its analog of especially cancer 埃姆库瑞医药品有限公司 2018-12-21 CN disclosed
CN-109053742-A New tricyclic compound ABBVIE 公司 2018-12-21 CN disclosed
CN-108884043-A Substituted piperidine compounds and uses thereof 武田药品工业株式会社 2018-11-23 CN disclosed
CN-107847765-A The piperidine derivative of 1,4 substitutions 赛福伦公司 2018-03-27 CN disclosed
CN-105408323-B Piperidines urea derivative 默克专利股份公司 2018-03-13 CN disclosed
CN-105358556-B New compound for selective histone deacetylase inhibitor and the pharmaceutical composition comprising it 株式会社钟根堂 2018-01-02 CN disclosed
CN-107428719-A 4-methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2017-12-01 CN disclosed
CN-106928203-A Heterocyclic amides as kinase inhibitors 葛兰素史密斯克莱知识产权发展有限公司 2017-07-07 CN disclosed
CN-106573006-A Heterocyclic amides of RIP1 kinase inhibitors as pharmaceuticals 葛兰素史密斯克莱知识产权发展有限公司 2017-04-19 CN disclosed
CN-104177468-B ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17 里亚塔医药公司 2017-04-12 CN disclosed